Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07118202) titled 'TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma' on Aug. 5.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Barbara Ann Karmanos Cancer Institute
Condition:
Hepatocellular Carcinoma Recurrent
Intervention:
Device: TheraBionic P1
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: August 31, 2025
Target Sample Size: 198
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07118202
Disclaime...